Treatment for Vitamin D Deficiency in Children

Initial Treatment Phase

For a child with severe vitamin D deficiency, a loading dose regimen is recommended to rapidly normalize levels, with a treatment regimen of 2,000 IU of vitamin D daily for 12 weeks, or alternative dosing of 50,000 IU every other week for 12 weeks, according to the American Journal of Kidney Diseases 1
The goal of treatment is to achieve a 25(OH)D level above 20 ng/mL, as recommended by Clinical Nutrition 2

Maintenance Phase

After the initial treatment phase, maintenance therapy with 600 IU of vitamin D daily is recommended for children 1-18 years, as suggested by Clinical Nutrition 2, 3

Monitoring

Recheck 25(OH)D levels after the 12-week treatment period to confirm normalization, as advised by the American Journal of Kidney Diseases 1
Once normalized, monitor 25(OH)D levels every 6-12 months, especially during winter months when sun exposure is limited, according to Clinical Nutrition 2

Clinical Considerations

At severe deficiency levels, the child may already have clinical manifestations of rickets that should be assessed, as noted by Pediatrics 4
Consider evaluating serum calcium, phosphorus, alkaline phosphatase, and parathyroid hormone levels to assess for metabolic bone disease, as recommended by Clinical Nutrition 5
Ensure adequate dietary calcium intake during treatment, as vitamin D improves calcium absorption, according to Nature Reviews Nephrology 6

Potential Pitfalls

Avoid excessive supplementation as vitamin D toxicity can occur, though it's rare at recommended doses, as warned by Clinical Nutrition 3
Ensure adherence to the treatment regimen, as inconsistent supplementation may lead to treatment failure, as emphasized by Nature Reviews Nephrology 6
Do not use active vitamin D analogs to treat nutritional vitamin D deficiency, as advised by the American Journal of Kidney Diseases 1

Vitamin D Supplementation Guidelines

Initial Treatment and Maintenance Phase

The American Academy of Clinical Nutrition recommends treatment dosing should be adjusted based on age: preterm infants should receive 200-1000 IU/day, term infants up to 12 months should receive 400 IU/day, and children 1-18 years should receive 400-600 IU/day 7, 8
The goal of treatment is to achieve serum 25(OH)D levels above 20 ng/mL (50 nmol/L), with a target serum 25(OH)D concentration of >50 nmol/L (20 ng/mL) 7
Maintenance therapy should include 400 IU/day for infants and 600 IU/day for children and adolescents 7

Safety Considerations

The National Kidney Foundation recommends tolerable upper intake levels by age group: infants 0-6 months should not exceed 1,000 IU/day, infants 7-12 months should not exceed 1,500 IU/day, children 1-3 years should not exceed 2,500 IU/day, children 4-8 years should not exceed 3,000 IU/day, and children and adolescents 9-18 years should not exceed 4,000 IU/day 7, 9
Prolonged daily intake up to 10,000 IU appears safe, but serum concentrations >375 nmol/L are associated with acute hypercalcemia and hyperphosphatemia 7, 8

Vitamin D Supplementation Guidelines

Treatment Regimens

For children with mild vitamin D deficiency (5-15 ng/mL), the American Academy of Pediatrics recommends 4,000 IU/day orally for 12 weeks or 50,000 IU every other week for 12 weeks 10
For children with vitamin D insufficiency (16-30 ng/mL), 2,000 IU daily or 50,000 IU every 4 weeks is recommended 10
Cholecalciferol (vitamin D3) appears to have higher bioefficacy than ergocalciferol (vitamin D2) for treating vitamin D deficiency 10

Causes and Prevention

Limited sun exposure is a common cause of vitamin D deficiency in children 11
Dietary sources of vitamin D include cod liver oil, fish, liver, egg yolk, and fortified milk 11

Treatment of Pediatric Vitamin D Deficiency

Diagnosis and Classification

Vitamin D insufficiency is defined as a serum 25-hydroxyvitamin D level of 20-30 ng/mL (50-75 nmol/L), and severe vitamin D deficiency is considered at levels <25-30 nmol/L (10-12 ng/mL), which significantly increases risk for rickets and osteomalacia 12

Treatment Regimens Based on Deficiency Severity

Maintenance Therapy

Children 1-18 years should receive 600 IU/day of vitamin D for maintenance therapy, and preterm infants should receive 200-400 IU/day 13

Special Considerations

Children with renal insufficiency may need higher or more frequent supplementation 12
For patients on parenteral nutrition (PN), monitor periodically for vitamin D deficiency, provide additional supplementation for patients with 25(OH)D levels <50 nmol/L, and consider oral supplementation for patients on partial PN and during weaning from PN 13

Safety and Upper Limits

Prolonged daily intake up to 10,000 IU appears safe, but serum concentrations >375 nmol/L are associated with hypercalcemia and hyperphosphatemia 13, 12

Clinical Pearls and Pitfalls

The goal of treatment is to achieve serum 25(OH)D levels above 20 ng/mL (50 nmol/L) 13

Vitamin D Dosing for Children

Standard Maintenance Dosing by Age

The European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), the American Academy of Pediatrics, and the Institute of Medicine recommend 400 IU/day for infants under 12 months and 600 IU/day for children and adolescents ages 1-18 years 14, 15, 16
Infants 0-12 months require 400 IU/day from all sources, as recommended by ESPGHAN, the American Academy of Pediatrics, and the Institute of Medicine 14, 15, 16
Children and adolescents 1-18 years require 600 IU/day from all sources, as recommended by ESPGHAN, the American Academy of Pediatrics, and the Institute of Medicine 14, 15, 16
Preterm infants on parenteral nutrition require 200-1000 IU/day (or 80-400 IU/kg/day) 16

Safety Thresholds - Upper Tolerable Limits

The Institute of Medicine established age-specific upper limits to prevent toxicity: 1,000 IU/day maximum for 0-6 months, 1,500 IU/day maximum for 7-12 months, 2,500 IU/day maximum for 1-3 years, 3,000 IU/day maximum for 4-8 years, and 4,000 IU/day maximum for 9-18 years 14, 15
Prolonged daily intake up to 10,000 IU appears safe, but serum concentrations >375 nmol/L are associated with acute hypercalcemia and hyperphosphatemia 14, 15
Acute vitamin D intoxication is rare and typically results from doses much higher than 10,000 IU/day 14

Special Populations Requiring Higher Doses

Children on parenteral nutrition need monitoring for deficiency, with additional supplementation if 25(OH)D falls below 50 nmol/L, as recommended by the Institute of Medicine 16

Monitoring Strategy

The target serum level is >50 nmol/L (20 ng/mL), which indicates sufficiency, as recommended by the Institute of Medicine, ESPGHAN, and the American Academy of Pediatrics 14, 15, 16
For patients on long-term PN, monitoring is required periodically for deficiency, as recommended by the Institute of Medicine 16

Management of Vitamin D Deficiency in Pediatrics

Treatment Approach

For children younger than 1 year, smaller doses of vitamin D are likely sufficient for treating deficiency, though specific pediatric dosing is not well-established, according to the American Journal of Kidney Diseases 17
The American Journal of Kidney Diseases recommends treating vitamin D deficiency with 2,000 IU daily or 50,000 IU every 4 weeks for moderate deficiency/insufficiency 17
Cholecalciferol (vitamin D3) is preferred over ergocalciferol (vitamin D2) due to higher bioefficacy, as stated by the American Journal of Kidney Diseases 17

Special Populations

Optimal dosing for children with Chronic Kidney Disease (CKD) stages 3-5 is not established, according to the American Journal of Kidney Diseases 17
The American Journal of Kidney Diseases suggests monitoring calcium and phosphorus closely to avoid hypercalcemia in children with CKD 17

Maintenance Therapy and Monitoring

For preterm infants on parenteral nutrition, the Clinical Nutrition journal recommends 200-1,000 IU daily (or 80-400 IU/kg/day) of vitamin D supplementation 18
The Clinical Nutrition journal advises to monitor periodically and provide additional supplementation if 25(OH)D falls below 50 nmol/L in children on long-term parenteral nutrition 18
Administering vitamins with lipid emulsion whenever possible can increase stability, as recommended by the Clinical Nutrition journal 18

Vitamin D Deficiency Treatment in Children

Concurrent Calcium Supplementation and Special Population Considerations

The American Academy of Pediatrics and other guideline societies recommend providing 250-500 mg/day of elemental calcium during vitamin D treatment to support bone mineralization and prevent hypocalcemia, particularly in children with low ionized calcium or elevated PTH at baseline 19
For children with nephrotic syndrome, monitor ionized calcium, 25-OH-D3, and PTH levels closely due to massive urinary losses of vitamin D-binding protein, and supplement with oral cholecalciferol or calcifediol plus calcium (250-500 mg/day) when levels are low or PTH is elevated 19

Vitamin D Toxicity Threshold in Infants

Understanding Toxicity Levels

The target therapeutic range for vitamin D sufficiency is 20-30 ng/mL (50-75 nmol/L) in infants, as recommended by the Clinical Nutrition guideline society 20

Monitoring Strategy

The Clinical Nutrition guideline society recommends monitoring serum 25(OH)D levels every 3-6 months for infants on vitamin D supplementation at or above upper tolerable limits, and checking levels 3-6 months after any dosage change 20
Annual monitoring is sufficient for standard maintenance doses (400 IU/day) of vitamin D supplementation in infants, according to the Clinical Nutrition guideline society 20

Vitamin D Monitoring and Supplementation in Children

Clinical Context and Decision Framework

The American Academy of Pediatrics recommends checking 25(OH)D levels in children with malabsorption conditions, such as chronic diarrhea, celiac disease, inflammatory bowel disease, or cystic fibrosis, as these conditions increase the risk of vitamin D deficiency 21
The National Kidney Foundation recommends annual monitoring of vitamin D levels in children with chronic kidney disease (stages 2-5), as these children are at higher risk of vitamin D deficiency and related bone health problems 22

Appropriate Supplementation Dosing and Monitoring

The American Academy of Pediatrics suggests that children with limited sun exposure, inadequate supplementation, and dark skin pigmentation in northern latitudes with poor dietary intake may require closer monitoring of vitamin D levels, although the exact supplementation dose is not specified 21
The National Kidney Foundation recommends annual monitoring of vitamin D levels in children with chronic conditions, such as chronic kidney disease, on long-term supplementation, with a target serum 25(OH)D level of >20 ng/mL (50 nmol/L) 22

Additional Considerations

The American College of Rheumatology recommends assessing dietary calcium intake, with a target of 700-1,000 mg/day for ages 1-3 years, as adequate calcium is necessary for vitamin D to support bone health 23

Management of Pediatric Vitamin D Deficiency with Bone Deformity

Special Considerations for Bone Deformity

The National Kidney Foundation recommends evaluating for secondary hyperparathyroidism, and if PTH remains elevated despite vitamin D repletion, increasing the dose of vitamin D and/or ensuring adequate calcium supplementation, in children with vitamin D deficiency and bone deformity (rickets) 24
The American Academy of Pediatrics suggests considering orthopedic consultation for severe bone deformities that may require surgical intervention after metabolic correction, in children with vitamin D deficiency and bone deformity (rickets) 24
A multidisciplinary approach, as recommended by the National Institute of Child Health and Human Development, is essential for treatment plans, which should be discussed in a multidisciplinary team setting before any surgical procedures, in children with vitamin D deficiency and bone deformity (rickets) 24

Treatment of Vitamin D Deficiency in Pediatric Patients with Special Considerations

Essential Co-Interventions

The American Academy of Pediatrics and other guideline societies recommend ensuring adequate calcium supplementation during treatment, with a calcium dose of 250-500 mg/day of elemental calcium, particularly critical in children with low ionized calcium or elevated PTH at baseline, to support bone mineralization and prevent hypocalcemia 25
For children with nephrotic syndrome, monitor ionized calcium, 25-OH-D3, and PTH levels closely due to massive urinary losses of vitamin D-binding protein, and supplement with oral cholecalciferol or calcifediol PLUS calcium (250-500 mg/day) when levels are low or PTH is elevated, as reduced ionized calcium and elevated PTH indicate the need for both vitamin D and calcium supplementation 25

Critical Pitfalls to Avoid

Do not compromise caloric intake with fluid restriction in children with nephrotic syndrome, as this can exacerbate vitamin D deficiency and related complications 25

Vitamin D Pharmacokinetics in Children

Half‑life and Storage

The half‑life of serum 25‑hydroxyvitamin D in children is about 2 weeks to 3 months, and the vitamin is stored in adipose tissue, theoretically allowing less frequent dosing schedules (e.g., weekly or bi‑weekly) while maintaining adequate levels. (Circulation Research 2018) 26

Vitamin D Supplementation Guidelines for Infants and Children

Dosing Recommendations

Rationale for Early Initiation

Safety Profile

Common Pitfalls to Avoid

Monitoring Recommendations

Persistent Seizures After Calcium Normalization

Red‑Flag Indicators

If seizures continue after serum calcium has been corrected to normal levels, clinicians should evaluate for alternative causes or co‑existing neurological disorders. 29

Vitamin D Supplementation Dosing for Preterm Infants

Recommended Dosing

Preterm infants, particularly those on parenteral nutrition, should receive vitamin D supplementation at 200–1,000 IU daily (≈80–400 IU/kg/day) to maintain adequate vitamin D status and support skeletal health. 30

Use of Daily Ergocalciferol 2000 IU in Children

Indications for High‑Dose Ergocalciferol (2000 IU)

In children with vitamin D insufficiency (serum 25‑hydroxyvitamin D ≈ 16–30 ng/mL), a therapeutic regimen of 2000 IU ergocalciferol daily or 50,000 IU every 4 weeks is recommended for repletion. 31
Pediatric patients with chronic kidney disease may require the higher 2000 IU daily dose to achieve adequate vitamin D status, although the optimal dosing schedule has not been definitively established. 31

Contraindicated or Inappropriate Uses

Active vitamin D analogues (calcitriol, alfacalcidol, doxercalciferol, paricalcitol) should not be used to treat nutritional vitamin D deficiency; they are reserved for specific conditions such as advanced chronic kidney disease. 31
In children with underlying conditions that increase sensitivity to vitamin D (e.g., chronic kidney disease, granulomatous disease), monitoring for hypercalcemia is essential when administering ergocalciferol. 31